Valuation: AbbVie Inc.

Market Cap 450B 395B 364B 337B 638B 43,080B 651B 4,380B 1,702B 21,082B 1,690B 1,653B 73,183B P/E 2026 *
30.7x
P/E 2027 * 23.9x
Enterprise Value 505B 443B 409B 378B 716B 48,343B 730B 4,915B 1,910B 23,657B 1,896B 1,854B 82,124B EV / Sales 2026 *
7.51x
EV / Sales 2027 * 6.82x
Free-Float
95.71%
Yield 2026 *
2.7%
Yield 2027 * 2.84%
1 day-0.37%
1 week+1.08%
Current month+0.85%
1 month+13.77%
3 months+19.94%
6 months+13.23%
Current year+11.07%
1 week 250.51
Extreme 250.51
261.64
1 month 215.37
Extreme 215.37
261.64
Current year 190.75
Extreme 190.75
261.64
1 year 184.63
Extreme 184.63
261.64
3 years 132.7
Extreme 132.7
261.64
5 years 105.56
Extreme 105.56
261.64
10 years 55.06
Extreme 55.0623
261.64
Manager TitleAgeSince
Chief Executive Officer 55 2024-06-30
Director of Finance/CFO 59 2022-06-22
Chief Tech/Sci/R&D Officer - 2024-02-29
Director TitleAgeSince
Director/Board Member 65 2012-12-31
Director/Board Member 74 2012-12-31
Director/Board Member 68 2012-12-31
Date Insider Type Main position Quantity % Market Cap.
06-29Free

Director

62 0.0000%
06-29Free

Director

134 0.0000%
05-07Free

Director

1,118 0.0001%
Change 5-day change 1-year change 3-year change Capi.($)
-0.34%+1.08%+33.73%+88.70% 450B
-1.10%+2.94%+57.75%+170.72% 1,102B
-0.53%+4.58%+70.49%+66.51% 643B
-1.35%+1.86%+29.96%+26.26% 336B
-0.71%+0.72%+28.85%+46.77% 288B
-1.31%-0.26%-28.18%-39.13% 222B
-0.10%+2.05%+24.15%+64.08% 199B
-0.89%+7.70%+22.16%+79.24% 169B
+0.31%+1.13%-5.74%-32.32% 137B
-3.77%+1.72%+8.63%+47.07% 133B
Average -0.97%+2.55%+24.18%+51.79% 367.77B
Weighted average by Cap. -0.89%+2.19%+39.47%+84.93%

Financials

2026 *2027 *
Net sales 67.24B 58.98B 54.45B 50.32B 95.37B 6,439B 97.28B 655B 254B 3,151B 253B 247B 10,938B 72.74B 63.8B 58.9B 54.43B 103B 6,965B 105B 708B 275B 3,408B 273B 267B 11,832B
Net income 14.35B 12.59B 11.62B 10.74B 20.36B 1,374B 20.76B 140B 54.29B 673B 53.9B 52.72B 2,335B 19.02B 16.69B 15.4B 14.23B 26.98B 1,822B 27.52B 185B 71.95B 891B 71.44B 69.87B 3,094B
Net Debt 54.97B 48.21B 44.51B 41.13B 77.96B 5,263B 79.52B 535B 208B 2,576B 206B 202B 8,941B 46.35B 40.65B 37.53B 34.68B 65.74B 4,438B 67.05B 451B 175B 2,172B 174B 170B 7,539B
Logo AbbVie Inc.
AbbVie Inc. specializes in therapeutic drug research and development. Its products are intended for treating rheumatoid arthritis, psoriasis, Crohn's disease, thyroid disease, Parkinson's disease, HIV, complications of mucoviscidosis, low testosterone levels, and complications associated with chronic renal disease. Net sales are distributed geographically as follows: the United States (76.2%), Germany (2.8%), Japan (2.1%), Canada (2%), China (1.6%), France (1.3%), the United Kingdom (1%), Spain (1%), Italy (0.9%), Brazil (0.8%), Australia (0.8%), and Other (9.5%).
Employees
57,000
Date Price Change Volume
26-07-08 US$253.83 -0.32% 2,652,873
26-07-07 US$254.65 -0.04% 8,238,267
26-07-06 US$254.76 -2.42% 8,580,220
26-07-02 US$261.07 +3.99% 7,114,422
26-07-01 US$251.06 -0.23% 6,987,982
Trader
Investor
Global
Quality
-
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
31
Last Close Price
254.65USD
Average target price
258.32USD
Spread / Average Target
+1.44%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ABBV Stock